July 29, 2014 5:44 AM ET


Company Overview of Anterogen Co., Ltd.

Company Overview

Anterogen Co., Ltd. offers research and development of cell therapy products and orphan drugs using adult stem cells. The company develops heart muscle regeneration technology using stem cells isolated from bone marrow. In addition the company operates in research and development activities for heart tissue regeneration. Anterogen Co., Ltd. was founded in 2000 and is based in Seoul, South Korea. Anterogen Co., Ltd. operates as a subsidiary of Bukwang Pharmaceutical Co., Ltd.

(Namsung Plaza, Gasan-dong) 405

130, Digital-ro


Seoul,  153-782

South Korea

Founded in 2000


82 2 2104 0391


82 2 2104 0393

Key Executives for Anterogen Co., Ltd.

Anterogen Co., Ltd. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
mgen, inc. Asia
Bio Technology Chemical Co. Ltd. Asia
Qurient Co.,Ltd Asia
Samsung Bioepis Co., Ltd. Asia
Metabolab, Inc. Asia

Recent Private Companies Transactions

Private Placement
August 23, 2013

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Anterogen Co., Ltd., please visit www.anterogen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.